CO6382140A2 - Composiciones de vacuna que comprenden una proteina de enlace del factor h mutada - Google Patents

Composiciones de vacuna que comprenden una proteina de enlace del factor h mutada

Info

Publication number
CO6382140A2
CO6382140A2 CO11055224A CO11055224A CO6382140A2 CO 6382140 A2 CO6382140 A2 CO 6382140A2 CO 11055224 A CO11055224 A CO 11055224A CO 11055224 A CO11055224 A CO 11055224A CO 6382140 A2 CO6382140 A2 CO 6382140A2
Authority
CO
Colombia
Prior art keywords
mutada
vaccine compositions
link protein
compositions understanding
factor link
Prior art date
Application number
CO11055224A
Other languages
English (en)
Spanish (es)
Inventor
Rachel Exley
Christoph Tang
Susan M Lea
Original Assignee
Imp Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imp Innovations Ltd filed Critical Imp Innovations Ltd
Publication of CO6382140A2 publication Critical patent/CO6382140A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CO11055224A 2008-10-25 2011-05-05 Composiciones de vacuna que comprenden una proteina de enlace del factor h mutada CO6382140A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0819633.9A GB0819633D0 (en) 2008-10-25 2008-10-25 Composition

Publications (1)

Publication Number Publication Date
CO6382140A2 true CO6382140A2 (es) 2012-02-15

Family

ID=40133849

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11055224A CO6382140A2 (es) 2008-10-25 2011-05-05 Composiciones de vacuna que comprenden una proteina de enlace del factor h mutada

Country Status (23)

Country Link
US (1) US20120052092A1 (cg-RX-API-DMAC7.html)
EP (2) EP3501534B1 (cg-RX-API-DMAC7.html)
JP (2) JP5676458B2 (cg-RX-API-DMAC7.html)
KR (3) KR20170000390A (cg-RX-API-DMAC7.html)
CN (2) CN105412920A (cg-RX-API-DMAC7.html)
AU (1) AU2009306114B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0919926A2 (cg-RX-API-DMAC7.html)
CA (1) CA2741619A1 (cg-RX-API-DMAC7.html)
CO (1) CO6382140A2 (cg-RX-API-DMAC7.html)
DK (1) DK3501534T5 (cg-RX-API-DMAC7.html)
ES (1) ES2970878T3 (cg-RX-API-DMAC7.html)
FI (1) FI3501534T3 (cg-RX-API-DMAC7.html)
GB (1) GB0819633D0 (cg-RX-API-DMAC7.html)
HR (1) HRP20240226T1 (cg-RX-API-DMAC7.html)
HU (1) HUE065348T2 (cg-RX-API-DMAC7.html)
LT (1) LT3501534T (cg-RX-API-DMAC7.html)
MX (1) MX2011004322A (cg-RX-API-DMAC7.html)
NZ (2) NZ601538A (cg-RX-API-DMAC7.html)
PL (1) PL3501534T3 (cg-RX-API-DMAC7.html)
PT (1) PT3501534T (cg-RX-API-DMAC7.html)
RU (1) RU2559528C2 (cg-RX-API-DMAC7.html)
SI (1) SI3501534T1 (cg-RX-API-DMAC7.html)
WO (1) WO2010046715A1 (cg-RX-API-DMAC7.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX343752B (es) 1998-05-01 2016-11-22 Novartis Vaccines & Diagnostics Inc Antigenos de neisseria meningitidis y composiciones que los contienen.
WO2000071725A2 (en) 1999-05-19 2000-11-30 Chiron S.P.A. Combination neisserial compositions
PT2275551E (pt) 1999-10-29 2015-06-29 Novartis Vaccines & Diagnostic Péptidos antigénicos de neisseria
ATE503837T1 (de) 2000-02-28 2011-04-15 Novartis Vaccines & Diagnostic Hybride expression neisserscher proteine
GB0118249D0 (en) 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
GB0121591D0 (en) 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
ATE492288T1 (de) 2002-10-11 2011-01-15 Novartis Vaccines & Diagnostic Polypeptidimpstoffe zum breiten schutz gegen hypervirulente meningokokken-linien
GB0227346D0 (en) 2002-11-22 2002-12-31 Chiron Spa 741
GB0408977D0 (en) 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
GB0524066D0 (en) 2005-11-25 2006-01-04 Chiron Srl 741 ii
US9579372B2 (en) 2008-02-21 2017-02-28 Glaxosmithkline Biologicals Sa Meningococcal fHBP polypeptides
EP2631245A1 (en) 2008-03-10 2013-08-28 Children's Hospital & Research Center at Oakland Chimeric factor H binding proteins (fHBP) containing a heterologous B domain and methods of use
HRP20201076T1 (hr) 2009-03-24 2020-10-30 Glaxosmithkline Biologicals Sa Adjuvantni vezujući protein meningokokalnog faktora h
WO2010127172A2 (en) 2009-04-30 2010-11-04 Children's Hospital & Research Center At Oakland Chimeric factor h binding proteins (fhbp) and methods of use
AU2010310985B2 (en) * 2009-10-27 2014-11-06 Glaxosmithkline Biologicals S.A. Modified meningococcal fHBP polypeptides
US9567377B2 (en) * 2010-03-10 2017-02-14 Glaxosmithkline Biologicals Sa Immunogenic composition
ES2661569T3 (es) 2010-03-30 2018-04-02 Children's Hospital & Research Center At Oakland Proteínas de unión al factor H (fHbp) con propiedades alteradas y métodos de uso de las mismas
US10478483B2 (en) 2010-06-25 2019-11-19 Glaxosmithkline Biologicals Sa Combinations of meningococcal factor H binding proteins
ES2654613T3 (es) 2012-02-02 2018-02-14 Glaxosmithkline Biologicals Sa Promotores para una expresión aumentada de proteínas en meningococos
CN104602704B (zh) 2012-06-14 2019-08-06 诺华股份有限公司 针对血清组x脑膜炎球菌的疫苗
AU2013295242C1 (en) 2012-07-27 2018-08-09 Institut National De La Sante Et De La Recherche Medicale CD147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia
US20160030544A1 (en) * 2013-03-14 2016-02-04 Isis Innovation Limited Immunogenic composition to neisseria
JP2016527278A (ja) 2013-08-02 2016-09-08 チルドレンズ ホスピタル アンド リサーチ センター オークランド 天然に生じないｈ因子結合タンパク質（ｆｈｂｐ）及びその使用の方法
SG10201907875TA (en) 2014-02-28 2019-09-27 Glaxosmithkline Biologicals Sa Modified meningococcal fhbp polypeptides
ES2922554T3 (es) 2014-07-23 2022-09-16 Childrens Hospital & Res Center At Oakland Variantes de proteínas de unión al factor H y métodos de uso de las mismas
EP3183266B1 (en) * 2014-08-20 2019-05-29 Stichting Sanquin Bloedvoorziening Factor h potentiating antibodies and uses thereof
GB201614687D0 (en) * 2016-08-31 2016-10-12 Univ Oxford Innovation Ltd fHbp scaffold
EP3607967A1 (en) 2018-08-09 2020-02-12 GlaxoSmithKline Biologicals S.A. Modified meningococcal fhbp polypeptides
BR112021012250A2 (pt) 2018-12-21 2021-09-08 Griffith University Composições, métodos e usos para induzir uma resposta imune
EP3997108A4 (en) * 2019-07-08 2024-03-20 Crapaud Bio, Inc. METHODS OF PRODUCING AND USING LIPOOLIGOSACCHARIDE COMPOSITIONS AND VACCINES
EP3999073A4 (en) 2019-07-17 2023-07-26 Gemini Therapeutics Sub, Inc. Factor h potentiating antibodies and uses thereof
TW202245836A (zh) 2021-02-19 2022-12-01 美商賽諾菲巴斯德公司 重組ｂ型腦膜炎球菌疫苗
TW202423477A (zh) 2022-08-03 2024-06-16 美商賽諾菲巴斯德公司 針對腦膜炎奈瑟氏菌b的含佐劑免疫原性組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786592A (en) * 1986-06-18 1988-11-22 Scripps Clinic And Research Foundation Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin
US5476784A (en) * 1993-04-06 1995-12-19 Rice; Peter A. Gonococcal anti-idiotypic antibodies and methods and compositions using them
GB0220194D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
MXPA05011110A (es) * 2003-04-16 2006-01-24 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de un padecimiento originado por meningococos.
MX2007008785A (es) * 2005-01-27 2008-02-15 Childrens Hosp & Res Ct Oak Vacunas de vesicula basadas en gna1870 para proteccion de amplio espectro contra padecimientos causados por neisseria meningitidis.
GB0524066D0 (en) * 2005-11-25 2006-01-04 Chiron Srl 741 ii
AU2007263531B2 (en) * 2006-06-29 2012-03-15 J. Craig Venter Institute, Inc. Polypeptides from neisseria meningitidis
NZ622048A (en) * 2009-08-27 2015-10-30 Novartis Ag Hybrid polypeptides including meningococcal fhbp sequences
ES2661569T3 (es) * 2010-03-30 2018-04-02 Children's Hospital & Research Center At Oakland Proteínas de unión al factor H (fHbp) con propiedades alteradas y métodos de uso de las mismas

Also Published As

Publication number Publication date
AU2009306114A1 (en) 2010-04-29
PL3501534T3 (pl) 2024-04-02
JP2012506411A (ja) 2012-03-15
BRPI0919926A2 (pt) 2016-02-16
US20120052092A1 (en) 2012-03-01
JP2015063558A (ja) 2015-04-09
JP5676458B2 (ja) 2015-02-25
CN102245202A (zh) 2011-11-16
CN105412920A (zh) 2016-03-23
FI3501534T3 (fi) 2024-02-09
EP3501534B1 (en) 2023-11-29
KR20110092282A (ko) 2011-08-17
LT3501534T (lt) 2024-03-12
AU2009306114B2 (en) 2015-10-01
HUE065348T2 (hu) 2024-05-28
EP2355845B1 (en) 2018-12-05
NZ601538A (en) 2014-01-31
MX2011004322A (es) 2011-06-16
EP3501534A1 (en) 2019-06-26
NZ592444A (en) 2012-11-30
JP6076326B2 (ja) 2017-02-08
KR20170000390A (ko) 2017-01-02
EP2355845A1 (en) 2011-08-17
GB0819633D0 (en) 2008-12-03
DK3501534T5 (da) 2024-09-02
WO2010046715A1 (en) 2010-04-29
DK3501534T3 (da) 2024-02-05
RU2559528C2 (ru) 2015-08-10
SI3501534T1 (sl) 2024-03-29
RU2011120706A (ru) 2012-11-27
ES2970878T3 (es) 2024-05-31
HRP20240226T1 (hr) 2024-05-10
PT3501534T (pt) 2024-02-07
KR20190011836A (ko) 2019-02-07
CA2741619A1 (en) 2010-04-29

Similar Documents

Publication Publication Date Title
CO6382140A2 (es) Composiciones de vacuna que comprenden una proteina de enlace del factor h mutada
UA118332C2 (uk) Білок, що зв'язує антиген cd27l
CY1120413T1 (el) Ειδικα εξανθρωπισμενα αντισωματα στην πρωτοϊνιδιακη μορφη του βητα-αμυλοειδους πεπτιδιου
CR20110466A (es) Anticuerpos biespecíficos anti-erbb-3/anti-c-met
ECSP13011139A (es) Anticuerpos contra la angiopoyetina 2 humana
EA201001639A1 (ru) Композиции и способы их получения и применения
MX375202B (es) Composiciones adyuvantes novedosas.
ECSP10010295A (es) Formulacion de anticuerpo
GT201100023A (es) Anticuerpos neutralizantes del virus anti - influenza a y usos de los mismos
BR112012008833A2 (pt) imunoglobulinas de dominio variavel duplo e usos das mesmas
MX353706B (es) Anticuerpos contra csf-1r humano y usos de los mismos.
CR20110166A (es) Anticuerpos biespecíficos anti-vegf/anti-ang-2
CY1117563T1 (el) Αντισωματα κατα her3 και χρησεις αυτων
EA201591888A1 (ru) Репликационно-дефектные вакцины и вакцинные векторы против флавивирусов
EA201590705A1 (ru) ПОЛУЧЕНИЕ РЕКОМБИНАНТНОЙ ВАКЦИНЫ В E.coli ПОСРЕДСТВОМ ЭНЗИМАТИЧЕСКОЙ КОНЪЮГАЦИИ
BR112014015851A2 (pt) proteínas de ligação específicas duplas direcionadas contra il-13 e/ou il-17
GT200800276A (es) Composiciones farmaceuticas estabilizadas que comprenden fesoterodina
BR112015018270A2 (pt) composições que compreendem 15-ohepa e métodos de uso das mesmas
CO6440541A2 (es) Virus de diarrea viral bovina con una proteina erns modificada
CR20110209A (es) Composición farmacéutica sólida
PE20081687A1 (es) Proteina de fusion
EA201790558A1 (ru) Композиция с пониженной иммуногенностью
BRPI0611820B8 (pt) método de identificar uma infecção por e. canis ou e. chaffeensis
BRPI0914940A8 (pt) Composições nutritivas contendo punicalaginas
BR112013003883A2 (pt) composições que compreendem paulownina e/ou extratos de paulônia e usos das mesmas

Legal Events

Date Code Title Description
FC Application refused